R. Carruthers

R. Carruthers

Plus aucun poste en cours

Fortune : 50 185 $ au 30/06/2026

68 ans
Health Technology
Producer Manufacturing
Commercial Services

Profil

R.
Michael Carruthers
is currently an Independent Director at OnKure Therapeutics, Inc. since 2024.
Former positions include Chief Financial Officer at Edgewise Therapeutics, Inc. from 2020 to 2025; Chief Financial Officer at Fresh Tracks Therapeutics, Inc. from 2017 to 2020; Chief Financial Officer at ClinOne, Inc. from 2018 to 2020; President and Chief Financial Officer at Alpine Immune Sciences, Inc. in 2017; President, Chief Financial Officer, and Secretary at Nivalis Therapeutics, Inc. in 2017; Chief Financial Officer and Head of Investor Relations at Array BioPharma, Inc. from 2013 to 2015; Independent Director at Elevation Oncology, Inc. from 2021 to 2025; Chief Financial Officer at OnKure, Inc. from 2019 to 2021; Chief Financial Officer at Sievers Instruments, Inc. from 1993 to 1998; Director at Pyxant Labs, Inc. from 2000 to 2012; Treasurer and Controller at Dover Corp.
Waukesha Division from 1989 to 1993; Treasurer and Controller at Waukesha Bearings Corp.; Chief Financial Officer at Vical, Inc.; Senior Auditor at Coopers & Lybrand LLP.
Education includes an MBA from The University of Chicago Booth School of Business and undergraduate studies at the University of Colorado Boulder.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 795 ( 0% ) 32 301 $ 30/06/2026
0,01%
04/06/2026 3 922 ( 0,01% ) 17 884 $ 30/06/2026

Postes actifs de R. Carruthers

SociétésPosteDébut

Anciens postes connus de R. Carruthers

SociétésPosteFin
EDGEWISE THERAPEUTICS, INC. Directeur Financier/CFO 10/11/2025
ELEN ONCO Directeur/Membre du Conseil 23/07/2025
FRESH TRACKS THERAPEUTICS, INC. Directeur Financier/CFO 01/10/2020
Directeur Financier/CFO 01/05/2020
President 01/08/2017
Voir l'expérience en détail de R. Carruthers

Formation de R. Carruthers

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

61

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Producer Manufacturing

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Producer Manufacturing

Electronic Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. R. Carruthers